EVELYN WHITLOCK named chief science officer of Patient-Centered Outcomes Research Institute.
JEFFREY MEDIN was named MACC (Midwest Athletes Against Childhood Cancer) Fund Endowed Professor at the department of pediatrics at the Medical College of Wisconsin.
PETER SCHULTZ was named CEO and STEVE KAY was named president of The Scripps Research Institute.
GILDA'S CLUB CHICAGO and other organizations across the country launched the It's About Time campaign, an initiative to raise awareness of metastatic breast cancer.
THE RIDE TO CONQUER CANCER raised $2.1 million for cancer research and accelerates transformational cancer discoveries at Johns Hopkins Kimmel Cancer Center, Sibley Memorial, Suburban and Howard County General Hospitals.
THOMAS JEFFERSON UNIVERSITY HOSPITAL and GenomOncology are co-developing a multi-assay integrated cancer profiling system.
THE EXPERIMENTAL THERAPEUTICS INSTITUTE at the Icahn School of Medicine at Mount Sinai and Regeneron Pharmaceuticals Inc. entered into an agreement with the goal of accelerating the discovery of fully-human antibodies directed against therapeutic targets being researched by Mount Sinai investigators.
FDA approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting.
SCIEX, a company focused on life science analytical technologies, announced a collaboration with the laboratory of Amanda Paulovich, of Fred Hutchinson Cancer Research Center, to make targeted proteomics in cancer research more reproducible and specific.
HUNTSMAN CANCER INSTITUTE became the first Mediso Preclinical Imaging Center of Excellence in North America.
